General. All reactions were carried out with standard Schlenk techniques under an argon or nitrogen atmosphere. Column chromatography was carried out on Wakogel 
S 2 (m, 2H), 1.92 (br s, 1H), 2.36 (s, 3H), 2.68 (d, J = 12.5 Hz, 1H), 2.88 (d, J = 12.5 Hz, 1H), 6.35 (s, 1H), 7.16 (d, J = 8.0 Hz, 2H), 2H) ; 13 C NMR (126 MHz, CDCl 3 ) δ 14. 1, 21.3, 23.1, 27.2, 38.5, 44.0, 76.0, 125.2, 129.0, 130.4, 131.3, 138.4, 146 27.2, 38.6, 44.1, 55.3, 76.0, 113.7, 126.7, 127.0, 129.0, 145.8, 159.9 ; IR (ν/cm 14.0, 14.1, 22.5, 23.1, 26.4, 27.3, 29.0, 30.7, 31.6, 38.6, 46.4, 76.5, 132.4, 151.8; ): 3348, 2924 , 2862 , 1458 HRMS (ESI) 
1-Butyl-3-(4-methoxyphenyl)cyclobut-2-enol (1c)
.
General Procedure for Palladium(0)-Catalyzed Ring-Opening Cross-Coupling of tert-

Cyclobutenols 1 with Organohalides 2 (GP-1).
A Schlenk tube was charged with Pd 2 (dba) 3 (2.3 mg, 2.5 µmol), XPhos (4.7 mg, 9.9 µmol), cyclobutenol 1 (0.120 mmol), organohalide 2 (0.100 mmol), and Ag 2 CO 3 (30.3 mg, 0.11 mmol), and the tube was evacuated and backfilled with nitrogen (liquid substrates were added via syringe after toluene). Toluene (0.50 mL) was added via a syringe through the septum, and the mixture was heated at 65 °C with stirring for the indicated period of time. The reaction mixture was filtered through a plug of Florisil ® washing with hexane-S 3 AcOEt (3:1), and the filtrate was concentrated. The residue was purified by preparative TLC on silica gel to afford ring-opened enone 3.
(E)-1-(4-Methylphenyl)-2-phenyl-1-octen-4-one (3a). The general procedure (GP-1) was followed using 1a (24.3 mg, 0.120 mmol) and 2a (17.1 mg, 0.100 mmol) for 6 h. Purification by preparative TLC on silica gel (hexane:AcOEt:toluene = 60:2:1, 4 times) yielded 3a (22.1 mg, 0.076 mmol, 76%) as a yellow oil. The Z-isomer (1.0 mg, 0.003 mmol, 3%) and (E)-2-phenyl-2-octen-4-one 4 (2.1 mg, 0.010 mmol, 9%) were also isolated. 8, 21.2, 22.2, 25.8, 42.2, 45.6, 126.2, 127.4, 128.45, 128.53, 129.1, 131.3, 134.6, 134.8, 137.0, 142.3, 209 (E)-1,2-Bis(4-methylphenyl)-1-octen-4-one (3b). The general procedure (GP-1) was followed using 1b (26.1 mg, 0.121 mmol) and 2a (17.1 mg, 0.100 mmol) for 11.5 h. Purification by preparative TLC on silica gel (hexane:AcOEt:toluene = 120:2:1, 5 times) yielded 3b (18.6 mg, 25.8, 42.1, 45.5, 126.0, 128.5, 129.1, 129.2, 130.5, 134.6, 134.8, 136.8, 137.3, 139.3, 209.3 2-(4-Methoxyphenyl)-1-(4-methylphenyl)-1-octen-4-one (3c) . The general procedure (GP-1) was followed using 1c (28.1 mg, 0.121 mmol) and 2a (17.0 mg, 0.099 mmol) for 10.5 h. MHz, CDCl 3 ) δ 13. 8, 21.2, 22.2, 25.7, 42.1, 45.5, 55.3, 113.9, 127.3, 128.4, 129.1, 129.8, 134.2, 134.6, 134.8, 136.7, 159.1, 209.4 22.3, 22.6, 26.0, 27.8, 29.0, 31.7, 37.9, 42.3, 45.5, 128.1, 128.3, 128.9, 135.1, 135.9, 136.1, 209. 2, 41.5, 126.2, 127.3, 128.2, 128.38, 128.43, 128.6, 129.1, 131.3, 133.2, 134.7, 134.8, 136.7, 136.9, 142.2, 197.9 ; IR (ν/cm 2, 21.6, 41.3, 126.2, 127.3, 128.35, 128.41, 129.1, 129.3, 131.2, 134.3, 134.7, 135.0, 136.8, 142.3, 144.0, 197.4 
(E)-4-(4-Methylphenyl)-3-phenyl-1-(2-thienyl)-3-buten-1-one (3g).
The general procedure (GP-1) was followed using 1g (25.7 mg, 0.113 mmol) and 2a (17.1 mg, 0.100 mmol) for 12 h. 127.4, 128.1, 128.5, 129.1, 131.7, 132.0, 133.7, 134.4, 134.6, 137.0, 142.0, 143.9, 190.6 (E)-1,2-Diphenyl-1-octen-4-one (3h). The general procedure (GP-1) was followed using 1a (24.3 mg, 0.120 mmol) and 2b (15.7 mg, 0.100 mmol) for 14. 8, 22.2, 25.8, 42.3, 45.5, 126.3, 127.2, 127.6, S 6 128.4, 128.5, 128.6, 131.3, 135.4, 137.6, 142.1, 209. (E)-1-(4-Methoxyphenyl)-2-phenyl-1-octen-4-one (3i). The general procedure (GP-1) was followed using 1a (24.3 mg, 0.120 mmol) and 2c (23.5 mg, 0.100 mmol) for 3 h. Purification by preparative TLC on silica gel (hexane:AcOEt = 15:1, twice) yielded 3i (18.1 mg, 0.059 mmol, 58%) as a yellow oil. 8, 22.2, 25.8, 42.3, 45.6, 55.3, 113.8, 126.2, 127.4, 128.5, 129.8, 130.0, 131.0, 134.1, 142.4, 158.7, 209.3 8, 22.2, 25.8, 40.4, 42.0, 45.8, 112.1, 125.6, 126.1, 127.0, 128.5, 129.7, 131.6, 132.1, 142.8, 149.6, 209.7 (E)-1-(4-Acetylphenyl)-2-phenyl-1-octen-4-one (3k). The general procedure (GP-1) was followed using 1a (24.3 mg, 0.120 mmol) and 2e (19.9 mg, 0.100 mmol) for 6 h. Purification by preparative TLC on silica gel (hexane:AcOEt = 20:1, twice, then hexane:AcOEt:toluene = 8, 22.2, 25.7, 26.6, 42.5, 45.5, 126.3, 128.0, 128.5, 128.6, 128.7, 130.3, 135.7, 137.3, 141.8, 142.4, 197.6, 208.4 
(E)-1-(3-Methylphenyl)-2-phenyl-1-octen-4-one (3l).
The general procedure (GP-1) was followed using 1a (24.3 mg, 0.120 mmol) and 2f (17.1 mg, 0.100 mmol) for 19 h. Purification by preparative TLC on silica gel (hexane:AcOEt:toluene = 60:2:1, 3 times) yielded 3l (19.2 mg, 0.066 mmol, 66%) as a yellow oil. 7, 20.0, 22.2, 25.7, 42.1, 45.3, 125.7, 126.2, 127.46, 127.53, 128.4, 128.5, 129.9, 130.5, 135.5, 136.8, 136.9, 141.8, 208.9 ; IR (ν/cm 8, 21.3, 22.3, 25.9, 42.1, 45.7, 126.2, 126.3, 127.4, 128.5, 128.8, 131.5, 135.1, 137.5, 137.9, 142.2, 209 
(E)-1-(2-Naphthyl)-2-phenyl-1-octen-4-one (3o).
The general procedure (GP-1) was followed using 1a (24.3 mg, 0.120 mmol) and 2i (20.7 mg, 0.100 mmol) for 11. 7, 22.1, 25.7, 42.1, 45.6, 125.0, 125.4, 125.98, 126.0, 126.1, 126.3, 127.7, 127.8, 128.4, 128.6, 129.2, 132.0, 133.5, 134.9, 137.2, 141.6, 208.9 (E)-7-Phenyl-7,10-undecadien-5-one (3p). The general procedure (GP-1) was followed using 1a (20.2 mg, 0.100 mmol) and 2j (14.6 mg, 0.121 mmol) for 9 h. Purification by preparative TLC on silica gel (hexane:AcOEt = 30:1, 3 times) yielded 3p (11.4 mg, 0.047 mmol, 47%) as a yellow oil. Hz, 1H), 7.18-7.32 (m, 5H); 13 C NMR (126 MHz, CDCl 3 ) δ 13. 8, 22.2, 25.8, 33.2, 41.7, 45.0, 115.5, 126.0, 127.1, 128.4, 129.2, 134.2, 135.8, 142.2, 208.4 Iodobenzenes 2 (GP-2) . A Schlenk tube was charged with Pd 2 (dba) 3 (2.3 mg, 2.5 µmol), XPhos (4.7 mg, 9.9 µmol), cyclobutenol 1 (0.120 mmol), organohalide 2 (0.100 mmol), and Ag 2 CO 3 (30.3 mg, 0.11 mmol), and the tube was evacuated and backfilled with nitrogen (liquid substrates were added via syringe after toluene).
General Procedure for Palladium(0)-Catalyzed Ring-Opening Cross-Coupling of tert-
Cyclobutenols 1 with ortho-Functionalized
Toluene (0.50 mL) was added via a syringe through the septum, and the mixture was heated at 65 °C with stirring for the indicated period of time. Then, t-BuOK (2 equiv) was added to the reaction mixture and the mixture was further heated for 2-4 h. The reaction mixture was filtered through a plug of Florisil ® washing with hexane-AcOEt (3:1), and the filtrate was concentrated. The residue was purified by preparative TLC on silica gel to afford naphthalene 5.
2-Pentanoyl-3-phenylnaphthalene (5a). The general procedure (GP-2) was followed using 22.1, 26.7, 42.6, 126.7, 127.6, 127.75, 127.80, 128.0, 128.6, 128.7, 128.9, 129.3, 131.8, 133.9, 137.2, 139.6, 140.9, 207.7 
2-Hexyl-3-pentanoylnaphthalene (5b).
The general procedure (GP-2) was followed using 2H), 2H), 2H), 3.02 (t, J = 7.5 Hz, 2H), 1H), 1H), 7.67 (s, 1H), 7.78 (d, J = 8.0 Hz, 1H), 7.85 (d, J = 8.0 Hz, 1H) 14.0, 14.1, 22.5, 22.6, 26.6, 29.4, 31.7, 31.8, 33.9, 41.9, 125.9, 127.1, 127.7, 128.3, 128.7, 129.0, 130.9, 134.4, 137.6, 138.9, 205.3 
2-Benzoyl-3-phenylnaphthalene (5c).
The general procedure (GP-2) was followed using 1e (26.7 mg, 0.120 mmol) and 2k (23.2 mg, 0.100 mmol) for 21 h. Purification by preparative TLC on silica gel (hexane:AcOEt = 20:1, twice) yielded 5c (15.3 mg, 0.050 mmol, 50%) as a colorless oil. 1 H NMR (500 MHz, CDCl 3 ) δ 7. 17-7.38 (m, 7H), 7.42-7.47 (m, 1H), 7.54-7.64 (m, 2H), 7.70-7.73 (m, 2H), 7.91-7.96 (m, 3H) 8, 127.2, 127.8, 127.9, 128.1, 128.3, 128.4, 129.1, 129.2, 129.3, 130.0, 131.5, 132.8, 134.0, 137.4, 137.7, 138.5, 140.3, 198.3 1-Amino-2-pentanoyl-3-phenylnaphthalene (5d). The general procedure (GP-2) was followed using 1a (24.3 mg, 0.120 mmol) and 2l (22.1 mg, 0.096 mmol) for 13 h. Purification by preparative TLC on silica gel (hexane:AcOEt = 15:1, twice) yielded 5d (17.4 mg, 0.057 mmol, 59%) as a yellow oil. 6, 22.1, 27.6, 44.4, 118.0, 118.9, 121.7, 122.7, 125.5, 127.5, 128.1, 128.68, 128.72, 128.8, 134.6, 139.0, 142.7, 143.4, 209 1-Amino-3-hexyl-2-pentanoylnaphthalene (5e). The general procedure (GP-2) was followed using 1d (26.7 mg, 0.127 mmol) and 2l (22.0 mg, 0.096 mmol) for 21 h. Purification by S 1 1 preparative TLC on silica gel (hexane:AcOEt = 30:1, twice) yielded 5e (10.0 mg, 0.032 mmol, 33%) as a yellow oil. 13.9, 14.0, 22.5, 22.6, 27.0, 29.3, 31.5, 31.6, 34.8, 44.7, 118.1, 121.1, 121.9, 122.2, 124.8, 127.1, 128.0, 134.5, 137.1, 140.0, 210.4 1-Amino-2-benzoyl-3-phenylnaphthalene (5f). The general procedure (GP-2) was followed using 1e (26.7 mg, 0.120 mmol) and 2l (22.0 mg, 0.096 mmol) for 14 h. Purification by preparative TLC on silica gel (hexane:AcOEt = 30:1, twice) yielded 5f (16.3 mg, 0.050 mmol, 52%) as a yellow oil. 5, 118.6, 121.6, 122.6, 125.6, 126.8, 127.6, 128.0, 128.1, 128.8, 129.1, 129.2, 131.7, 134.9, 139.9, 140.3, 141.9, 144.2, 200.4 
2,4-Diphenyl-3H-benzo[b]azepine (6).
The general procedure (GP-1) was followed using 1e (26.7 mg, 0.120 mmol) and 2m (21.9 mg, 0.100 mmol) for 20 h. Purification by preparative TLC on silica gel (hexane:AcOEt = 30:1, 3 times) yielded 6 (12.8 mg, 0.043 mmol, 43%) as a yellow solid. 9, 123.9, 126.79, 126.83, 126.9, 127.88, 127.9, 128.0, 128.5, 128.6, 128.8, 129.5, 130.1, 130.5, 134.9, 138.2, 139.9, 146.8, 157.3; HRMS (ESI) 8, 17.6, 29.0, 39.3, 125.7, 126.0, 126.6, 127.0, 128.0, 128.4, 128.7, 130.5, 130.7, 136.2, 139.6, 145.4, 155.3, 200.4 
